Pull up a chair for this high-energy collaborative session where you will join your industry peers to dissect the “Holy Trinity” of RLT design and solve complex integration puzzles. It’s time to trade insights, challenge traditional selection criteria, and then share your group’s top 3 thoughts and discussion points back to the room!

• Bringing together preclinical and early clinical perspectives to explore how to optimize RLT design for efficacy, safety, and translational readiness
• Balancing isotope properties, emission type, and half-life with clinical objectives
• Selecting chelation strategies to ensure stability, delivery, and safety
• Matching targeting moieties to tumor biology and therapeutic goals